Chemotherapy of Ocular Viral Infections Flashcards

1
Q

What are the stages for the multiplication cycle of a virus?

A
Adsorption
Penetration
Uncoating
Biosynthesis
Maturation
Release
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Is it normal for a virus to have both DNA and RNA?

A

Not normally, but some viruses (DNA based) keep extra RNA to help speed up the replication

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How is adsorption of a virus into the host done?

A

Usually by electrostatic attraction; some viral particles can bind to outer membrane receptor sites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How is penetration of a virus into a host cell done?

A

Usually acomplished by fusion of viral envelop or coat with the host cell
Or pinocytosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

When does uncoating occur?

A

During fusion or once the virus enters the cytoplasm, DNA/RNA passing into cell nucleus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe the biosynthesis stage of the viral multiplication cycle

A

Replicating more DNA/RNA via transcription to make viral progeny using the host cells’ apparatus. (Viral enzymes and proteins produced by the host)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe the maturation stage of the viral replication cycle

A

Assembly phase
Combining of parts to mak ethe viable viral progeny
Some of this occurs in the nucleus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe the release stage of the viral replication cycle

A

Generally occurs with lysis and death of the host

Some of this is done via exocytosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Talk about the principles of antiviral agents

A

To be effective must act on intracellular level (serious problem with selectivity between virus and host)
Enzymes used by viruses are not native and can direct antiviral action against the viral enzymes.
Can also block viral fusion or by preventing the uncoating/assembly
Virally infected cells have a higher metabolism and take up more of the antiviral for example than normal cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe how resistance to antivirals can form

A

Can occur with antiviral use
Anticipate increased resistance
Develop and use newer drugs on more viral conditions
Use of multiple drugs has prevented some resistance
One mechanism of resistance is decreased phosphorylation of antivirals, thus inhibiting their ability to kill viral infections
Another mechanism is accumulation of mutations to develop resistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe the general toxicities seen with antiviral use

A

Any rapidly dividing cell will also be affected by the antivirals
Stomatitis (inflammation of mucous membrane of mouth), anorexia, nausea, vomiting and weight loss
Occasionally see alopecia (baldness), blood dyscarsias (abnormal material present in blood), bone marrow depression, kidney/liver impairment and convulsions
Rarely get neurological disorders - insomnia, depression and dizziness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe the MOA, class, spectrum and toxicities for Idoxuridine

A

Deoxy-thymidine(Nucleotide) Analog; First and Prototypical Agent
0.1% solution (not available in the US anymore)
Spectrum - Herpes Simplex
Mimicks substrate that is phosphorylated by thymidine kinase to become an active cytotoxic metabolite.
Toxicity - Highly significant ocular toxicity, directly blocking DNA synthesis in normal cells.
Acute ocular toxicities - pain, photophobia, mild edema of the lids, punctate epithelial keratopathy, limbal follicles, follicular conjunctival response, ptosis, allergic reactions and permanent punctal stenosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe the MOA, class, spectrum and toxicities for Trigluridien (Viroptic)

A

Nucleotide Analog; 1.0% Solution
Spectrum - In vivo and in vitro; HSV I and II and vaccina
Good ocular penetration and more effective than idoxuridine
Metabolized to triphosphate derivative and inhibits thymidine kinase very effectively like IDU
Toxicities less severe or frequent when compared to IDU or vidarabine
Transient stinging/burning, lid edema, conjunctival hyperemia, chemosis, keratitis, corneal edema and slower healing,

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Steroids are contraindicated in which viral condition?

A

Any herpetic lesion involving the epithelial layer of the cornea, can cause multiplication of the HSV keratitis

Except in the case of deep stromal disease without any epithelial involvement. But start with a low dose and taper ASAP.

 Rule of thumb is if there is active epithelial damage, no steroid unless there is underlying cause (scarring/white cell concretions in cornea) then use it; but keep in mind you have the HSV infection must be controlled first as the steroids speed the viral replication!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

HSV develops resistance to the nucleotide analogs by what suspected mechanism?

A

Altered binding to enzyme/substrate to decrease the phosphorylation of the antiviral.
Readily seen in vitro (in test tube)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Why can nucleotide analog antivirals not be taken orally?

A

Very rapidly inactivated by GI enzyme nucleotidase

17
Q

Describe the MOA, class, spectrum and toxicities for Acyclovir (Zovirax)

A

Oral, topical, IV not topical; Acyclic Deoxy-guanosine derivative (Nucleotide derivative)
Affects herpes-zoster, epstein-barr, CMV (lesser) and doesn’t effect vaccina, adeno virus or RNA viruses
Highly selective action; preferential phosphorylation of acyclovir molecule by thymidine kianse into triphosphate acyclovir that is worked into the DNA. Very effective. (Especially in vitro)
Resistance to acyclovir seen in vaccina and some HSV I due to substrate specificity in thymidine kinase.
Topical toxicities - minimal, burning, stinging and some punctate keratitis
Systemic - NVD, headache, skin rash
No healing/immunosuppression.

18
Q

Besides the listed viruses that acyclovir (zovirax) can treat, what other conditions has it been shown to be good in treating?

A

Herpes Zoster Ophthalmicus Keratoconjunctivitis - Shown to decrease the severity and duration of the outbreak/systemic conditions, and especially in reducing the incidence of neurotrophic pain post infection

19
Q

When comparing Acyclovir (Zovirax) to Famiciclovir (Famvir) and Valacyclovir (Valtrex) how do the latter two differ from acyclovir?

A

Fewer doses per day

20
Q

Describe the MOA, class, spectrum and toxicities for Ganciclovir (Cytovene)

A

Oral/Injectable; Nucleotide analog (requires phosphorylation)
Treats immunocompromised patients with CMV Retinitis/preventing CMV retinitis in transplant patients
Must be phosphorylated to be active, some more selectivity in CMV infected cells as well as being more sensitive to ganciclovir
Resistance possible and cross resistant with cidofovir
Toxicities - Retinal Detachment (not sure why), Bone marrow depression leading to agranulocytosis and thrombocytopenia

21
Q

Describe the MOA, class, spectrum and toxicities for Cidofovir (Vistide)

A

Derivative of ganciclovir; acyclic deoxy-guanosine analog (nucleotide analog)
Injected/IV
A newer compound compared to ganciclovir
Resistance possible and cross resistance with ganciclovir
Toxicities
Dose Dependent Nephrotoxicity
Proteinuria
Increased serum creatnine
NVD, anorexia, abdominal pain, hair loss, rash, fever, anemias, amblyopia, conjunctivitis and hypotony

22
Q

When is it indicated to use ganciclovir or cidofovir?

A

Sight/Life threatening infection that hasn’t responded to other treatments
Ganciclovir and cidofovir are toxic to normal cells.

23
Q

Describe the MOA, class, spectrum and toxicities for Foscarnet (Foscavir)

A

Pyrophosphate derivative; powder only, meant for injections
Effective against all herpes group viruses, but used for CMV retinitis exclusively (and in the AIDs patients)
Doesn’t need to be phosphorylated to disrupt DNA polymerase and reverse transcriptase like nucleotide analogs
Taken up by viral rapidly dividing cells more than normal cells; relatively selective
Toxicities - Frequent decreased renal function
Bone marrow depression, fever, NVD, anemia, headache and seizures

24
Q

Describe the MOA, class, spectrum and toxicities for Fomivirsen (Vitravene)

A

Antisense Agent; Used for intravitreal injections (but removed)
“Viralstatic” (not a cure)
Oligonucletide blocking expression of 2 specific viral proteins (inhibits translation of mRNA)
Does not interfere with other antivirals and a great combination drug
Toxicity - Less frequent/severe compared to other antivirals, mostly to intraocular structures - Iritis, increased IOP, vitritis and cataracts

25
Q

Describe the MOA, class, spectrum and toxicities for Amantadine (Symmetrel)

A

Anti-influenza agent (dopamine agonist); prophylactic treatment
Only effective against Influenza A and not B
Significant resistance being developed
Inhibits uncoating of virus/interfering with viral assembly via affecting viral M2 protein.
Toxicities - Generally well tolerated, but careful as it is a dopamine agonist.
Blurred vision, hallucinations, confusion, anxiety, dizziness, orthostatic hypotension, depression, psychosis and heart failure
Can increase actions of anticholinergics

26
Q

Describe Zanamivir (Relenza) and Oseltamivir (Tamiflu)

A

Neuramindase inhibitors; Anti-influenza agents
Good against Influenza A and B
Inhibits the neuraminidase enzyme required for viral release.
Toxicities
Some bronchospams associated with zanamivir (relenza)
Some nausea associated with oseltamivir (Tamiflu)

27
Q

What are the five categories of anti-HIV agents?

A

Nucleoside/Nucleotide Reverse Transcriptase Inhibitors
Non-Nucleotide Reverse Transcriptase Inhibitors
Protease Inhibitors
Fusion/Entry Inhibitors
Integrase Inhibitors

28
Q

What drugs are Nucleoside/Nucleotide Reverse Transcriptase Inhibitors?

A

Zidovudine (Retrovir, AZT)
Zalcitabine (Hivid, ddC)
Didanosine (Vldex, ddl)

Treats HIV
Must be triphosphorylated to active agent; inhibits reverse transcriptase to inhibit DNA elongation
Toxic to normal cells.

29
Q

What drugs are non-nucleotide reverse transcriptase inhibitors?

A

Nevirapine (Viramune)
Delavirdine (Rescriptor)

Treats HIV-1 and HIV-2
Doesn’t need to be triphosphorylated to be activated. Binds to a more downstream part of DNA replication to alter enzyme conformation
Resistance develops rapidly
Minor toxicities (rash, headache, hepatitis sometimes)

30
Q

What drugs are Protease Inhibitors?

A
Ritonavir (Norvir)
Indianvir Sulfate (Crixivan)
Saquinavir Mesylate (Invirase)

Potent inhibitor of HIV-1 replication
Inhibits enzyme needed to cleave viral polyprotein precursors that are essential for viral maturation
Toxicities - Tend to be mild, but slows other drug metabolisms and can be fatal

31
Q

What drugs are contraindications for a person taking a protease inhibitor?

A

Antiarrhythmics
Anticoagulants
Benzodiazepines (including alcohol)

32
Q

What drugs are Fusion/Entry Inhibitors?

A

Enfuviritide (Fuzeon)

Newest approach to treating HIV
Binds to viral gp41 surface protein to prevent it from intiating conformation changes to allow fusion with host membrane.
Toxicities - Local redness, pain, nodules and cysts
Eosionophillia possible, much more likely to have bacterial pneumonia as well

33
Q

Describe Maraviroc (Selzentry)

A

Entry inhibitors

Treats HIV
Binds to CCR5-trophic HIV-1 R5 virus and blocks viral entry.
Toxicities - cough, fever, dizziness, headache, lowered blood pressure, nausea and bladder irritation

34
Q

What drugs are Integrase Inhibitors?

A

Raltegravir (Isentress)

Treats HIV
Inhibition of integrase enzyme to prevent viral DNA from integrating into human host DNA.
Common toxicities - Diarrhea, nausea, headache and fever

35
Q

How would one treat Hepatitis C?

A
Combo drug therapy is most promising
o	Ribivarin – Inhibits viral RNA polymerease, thus inhibiting protein synthesis
o	Peginterferon alpha – inhibits viral replication, also has antiproliferative, and immunomodulatory effects
o	Boceprevir (Victrelis) – binds to and inhibits specific Hep C protease
o	Telaprevir (Incivek) – binds to and inhibits specific Hep C protease